Soliqua® Phase 3 results significantly lowered blood sugar levels compared to GLP-1 receptor agonist treatments

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach